Regulação e direito · 30/11/20071 min de leitura
Prospective Grant of Exclusive License: Development of FDA Approved HIV Resistance Diagnosis Kit
Tradução automática local · Idioma original da fonte
Resumo
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the invention embodied in U.S. Patent No. 5,714,313, issued February 03, 1998, entitled "Simple Method For Detecting Inhibitors Of Retroviral Replication" (HHS Ref. E-054-1991/ 1-US-01) (Inventors: David Garfinkel, Joan Curcio, Dwight Nissley and Jeffrey Strathern) (NCI), to AmiKana.BioLogics (Hereafter AmiKana), having a place of business in France. The patent rights in these inventions have been assigned to the United States of America.